EVOKE PHARMA, INC. Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31)
EVOKE PHARMA, INC. reported Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) of $12 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EquityIssuancePerShareAmount · last filed 2015-03-04
- EVOKE PHARMA, INC. development stage entities, equity issuance, per share amount (deprecated 2015-01-31) for fiscal 2014 was $12.00, a 0.00% change from fiscal 2013.
- EVOKE PHARMA, INC. development stage entities, equity issuance, per share amount (deprecated 2015-01-31) for fiscal 2013 was $12.00.
USD
| Period end | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 12 month |
|---|---|
| 2014-12-31 | $12.00 10-K · filed 2015-03-04 |
| 2013-12-31 | $12.00 10-K · filed 2014-03-25 |
USD/shares
| Period end | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 12 month |
|---|---|
| 2014-12-31 | $12.00 10-K · filed 2015-03-04 |